Bryan M. Reasons

Chief Financial Officer, Impax Laboratories, LLC.

Companies

Keenova Therapeutics plcChief financial officer Mar 21, 2019 to Sep 25, 2025¹
Aclaris Therapeutics, Inc.Board member Apr 23, 2018 to Jun 4, 2024²
Societal CDMO, Inc.Board member Mar 6, 2017 to Apr 8, 2024³
Amneal Pharmaceuticals, Inc.Chief financial officer May 8, 2018 to Aug 23, 2018⁴

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

As of each latest filing. The line shows shares held over time.

Jan 1, 2025Shares withheld for tax 1,724 shares of Keenova Therapeutics plc⁶
Jan 1, 2025Exercised options 6,838 shares of Keenova Therapeutics plc⁶
Jun 1, 2024Exercised options 4,660 shares of Aclaris Therapeutics, Inc.⁵
Apr 8, 2024Returned to company 73,620 shares at $1.10 of Societal CDMO, Inc.⁷
Apr 8, 2024U 217,429 shares at $1.10 of Societal CDMO, Inc.⁷
Nov 14, 2023Returned to company 96,660 shares of Keenova Therapeutics plc⁸
Aug 28, 2023Bought 62,500 shares at $0.40 of Societal CDMO, Inc.⁹
Aug 17, 2023Shares withheld for tax 15,976 shares at $0.69 of Keenova Therapeutics plc¹⁰
Jun 2, 2023Exercised options 4,507 shares of Aclaris Therapeutics, Inc.¹¹
May 17, 2023Granted 73,620 shares of Societal CDMO, Inc.¹²
Dec 14, 2022Granted 112,636 shares of Keenova Therapeutics plc¹³
Jun 16, 2022Returned to company 11,593 shares of Keenova Therapeutics plc¹⁴
Jun 3, 2022Exercised options 3,356 shares of Aclaris Therapeutics, Inc.¹⁵
May 18, 2022Granted 87,500 shares of Societal CDMO, Inc.¹⁶

The numbers on this page point here. Each one links to the record it came from.